Clinical Trials Directory

Trials / Completed

CompletedNCT00612326

Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging

Status
Completed
Phase
Study type
Observational
Enrollment
26 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to to find out if the MRI and PET scans can truly stage patients with bladder cancer. Both scans use newer ways to find out if your disease has grown beyond the bladder. The radioactive tracer used for the PET scan is called C-11 Acetate. We want to see if PET scan will be able to take a picture of the inside of your body that is better than other scans such as the CT scan and MRI. Therefore, the findings of the PET scan will be compared with other imaging studies as well as the surgical findings.

Conditions

Interventions

TypeNameDescription
PROCEDUREMRI and PET scanning proceduresa CT scan, MRI, and C-11 Acetate PET scan. All these scans will be done as an outpatient. After you finish these scans, your doctor will schedule you for surgery to remove your bladder and lymph nodes.

Timeline

Start date
2004-06-01
Primary completion
2008-03-01
Completion
2008-03-01
First posted
2008-02-11
Last updated
2015-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00612326. Inclusion in this directory is not an endorsement.